MCID: CHL034
MIFTS: 9

Childhood Malignant Hemangiopericytoma

Categories: Cancer diseases

Aliases & Classifications for Childhood Malignant Hemangiopericytoma

MalaCards integrated aliases for Childhood Malignant Hemangiopericytoma:

Name: Childhood Malignant Hemangiopericytoma 12 74
Malignant Pediatric Hemangiopericytoma 12

Classifications:



External Ids:

Disease Ontology 12 DOID:7731
NCIt 51 C8090
UMLS 74 C0279983

Summaries for Childhood Malignant Hemangiopericytoma

MalaCards based summary : Childhood Malignant Hemangiopericytoma, is also known as malignant pediatric hemangiopericytoma. The drugs Mechlorethamine and Ifosfamide have been mentioned in the context of this disorder.

Related Diseases for Childhood Malignant Hemangiopericytoma

Symptoms & Phenotypes for Childhood Malignant Hemangiopericytoma

Drugs & Therapeutics for Childhood Malignant Hemangiopericytoma

Drugs for Childhood Malignant Hemangiopericytoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 36)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Mechlorethamine Approved, Investigational Phase 3 51-75-2 4033
2
Ifosfamide Approved Phase 3,Phase 2 3778-73-2 3690
3
Doxorubicin Approved, Investigational Phase 3,Phase 2,Phase 1 23214-92-8 31703
4
Etoposide Approved Phase 3,Phase 2 33419-42-0 36462
5
Dactinomycin Approved, Investigational Phase 3,Phase 2 50-76-0 457193 2019
6
Cyclophosphamide Approved, Investigational Phase 3,Phase 2 6055-19-2, 50-18-0 2907
7
Vincristine Approved, Investigational Phase 3,Phase 2 2068-78-2, 57-22-7 5978
8
Epirubicin Approved Phase 3,Phase 2 56420-45-2 41867
9
Carboplatin Approved Phase 3,Phase 2 41575-94-4 38904 10339178 498142
10
Doxil Approved June 1999 Phase 3,Phase 2,Phase 1 31703
11 Anti-Bacterial Agents Phase 3,Phase 2,Phase 1
12 Alkylating Agents Phase 3,Phase 2
13 Antibiotics, Antitubercular Phase 3,Phase 2,Phase 1
14
Isophosphamide mustard Phase 3,Phase 2 0
15 Antineoplastic Agents, Alkylating Phase 3,Phase 2
16 Topoisomerase Inhibitors Phase 3,Phase 2,Phase 1
17 Nucleic Acid Synthesis Inhibitors Phase 3,Phase 2
18 Immunosuppressive Agents Phase 3,Phase 2
19 Immunologic Factors Phase 3,Phase 2
20 Antirheumatic Agents Phase 3,Phase 2,Phase 1
21 Antineoplastic Agents, Phytogenic Phase 3,Phase 2
22 Anti-Infective Agents Phase 3,Phase 2
23 Etoposide phosphate Phase 3,Phase 2
24 Antimitotic Agents Phase 3,Phase 2
25
Lenograstim Approved, Investigational Phase 2 135968-09-1
26
Celecoxib Approved, Investigational Phase 1 169590-42-5 2662
27 Peripheral Nervous System Agents Phase 1
28 Anti-Inflammatory Agents Phase 1
29 Analgesics, Non-Narcotic Phase 1
30 Cyclooxygenase Inhibitors Phase 1
31 Cyclooxygenase 2 Inhibitors Phase 1
32 Anti-Inflammatory Agents, Non-Steroidal Phase 1
33 Analgesics Phase 1
34 Antibodies Phase 1
35 Antibodies, Monoclonal Phase 1
36 Immunoglobulins Phase 1

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue Sarcoma Unknown status NCT00334854 Phase 3 doxorubicin hydrochloride;ifosfamide
2 Surgery Followed by Chemotherapy in Treating Young Patients With Soft Tissue Sarcoma Completed NCT00002898 Phase 3 carboplatin;cyclophosphamide;epirubicin hydrochloride;etoposide;ifosfamide;vincristine sulfate
3 Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal Tumors Completed NCT00025441 Phase 2 carboplatin;cyclophosphamide;doxorubicin hydrochloride;epirubicin hydrochloride;etoposide;ifosfamide;vincristine sulfate
4 Celecoxib and Radiation Therapy in Treating Patients With Stage II or Stage III Soft Tissue Sarcoma of the Arm, Hand, Leg, or Foot That Has Been Removed by Surgery Completed NCT00450736 Phase 1 celecoxib
5 Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma Completed NCT00720174 Phase 1 Doxorubicin Hydrochloride

Search NIH Clinical Center for Childhood Malignant Hemangiopericytoma

Genetic Tests for Childhood Malignant Hemangiopericytoma

Anatomical Context for Childhood Malignant Hemangiopericytoma

Publications for Childhood Malignant Hemangiopericytoma

Variations for Childhood Malignant Hemangiopericytoma

Expression for Childhood Malignant Hemangiopericytoma

Search GEO for disease gene expression data for Childhood Malignant Hemangiopericytoma.

Pathways for Childhood Malignant Hemangiopericytoma

GO Terms for Childhood Malignant Hemangiopericytoma

Sources for Childhood Malignant Hemangiopericytoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....